Market News

US News

20 stories
acceswire

American Rebel Holdings, Inc. (OTCID:AREB) Advances America 250 Brand Amplification Strategy for American Rebel Light Beer - America's Patriotic Beer with Independence Day Weekend Activation in Gettysburg, PA

American Rebel Founder and CEO Andy Ross to perform at The Barn Resort as American Rebel Light Beer - America's Patriotic, GOD FEARING, CONSTITUTION LOVING, NATIONAL ANTHEM SINGING, STAND YOUR GROUND BEER - leverages Fourth of July fanfare, live consumer engagement, retailer support, distributor mo…

ACCESS Newswire en
StocksUS
globenewswire

Eos Energy Announces Commencement of Rights Offering

EDISON, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- NASDAQ:EOSE)">Eos Energy Enterprises, Inc. NASDAQ:EOSE ("Eos" or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long duration energy storage (LDES) systems sourced and manufactured in the United State…

GlobeNewswire en
ETFsStocksUS
globenewswire

Northern Technologies International Corporation to Announce Fiscal 2026 Third-Quarter Financial Results and Host Conference Call

MINNEAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation NASDAQ:NTIC today announced that it expects to release its fiscal 2026 third-quarter financial results on Thursday, July 9, 2026, before the market opens. A copy of the news release will be available on t…

GlobeNewswire en
ETFsStocksUS
globenewswire

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

BOULDER, Colo., July 02, 2026 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. NASDAQ:OKUR, a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced that it will host a virtual key opinion leader (KOL) event on Wednesday, July 15, 2026 at 11:00 AM ET…

GlobeNewswire en
StocksUS
globenewswire

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. NASDAQ:RVMD, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 clinical trials evaluating zoldonrasib, its oral RA…

GlobeNewswire en
StocksUS
globenewswire

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Partnership employs commercial use of drone autonomy software for large-scale ecosystem monitoring in endangered marine environmentsAUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc. (“Swarmer” or the “Company”) NASDAQ:SWMR, a drone autonomy software company whose technology has support…

GlobeNewswire en
StocksUS